VJHemOnc is committed to improving our service to you

Regulating HS1 function in response to ibrutinib therapy in CLL

VJHemOnc is committed to improving our service to you

Here, Cristina Scielzo, PhD, IRCCS, San Raffaele Scientific Institute, Milan, Italy, discusses the how 3D-culture of tumor cells within a bioreactor has helped identify the bone marrow as a key regulator of HS1 function when exposed to ibrutinib therapy. This interview took place at the 18th International Workshop on Chronic Lymphocytic Leukemia (iwCLL) Biennial Meeting, held in Edinburgh, UK.


Warning: count(): Parameter must be an array or an object that implements Countable in /home/vjhemonc/public_html/wp-content/themes/vj/single.php on line 241
Share this video  

Warning: Invalid argument supplied for foreach() in /home/vjhemonc/public_html/wp-content/themes/vj/single.php on line 436

Sign-up for our Newsletter!

Keep up to date with all the latest news with our monthly newsletter